(2022) reported JUN, an oncogenic transcription factor, as a regulator of glycolytic metabolism in AML, since it increases the expression of hexokinase I (HKI) and HKII, glucose phosphate isomerase (GPI), phosphofructo-1-kinase (PFKP), aldolase A (ALDOA), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), phosphoglycerate kinase (PGK1), enolase 1 (ENO1), and PKM
Some of the side effects we found, like nausea, are well known, and that shows the method is picking up a real signal, said senior author Sharath Chandra Guntuku in a press release
24 and 48 h later, viral supernatant was collected and filtered through a 0.45 m filter
[5] Male patients tend to be a few years older than female patients
[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Masson W., Lobo M., Nogueira J.P., Rodriguez-Granillo A.M., Barbagelata L.E., Siniawski D